NeurologyLive® Friday 5 — May 16, 2025
FDA Clears Lumipulse's Plasma Ratio as First Blood Test for Diagnosing Alzheimer Disease
FDA Approves First Autoinjector Form of DHE for Acute Migraine and Cluster Headache
Plasma GFAP May Enrich Patient Selection, Reduce PET Scans Required for Alzheimer Trials